NYU Langone Medical Center awarded $10 million NIMH grant

October 14, 2009

NYU Langone Medical Center has received a five-year, $10 million grant from the National Institute of Mental Health (NIMH) to establish a Silvio O. Conte Center for the Neuroscience of Mental Disorders. The center, named after the late Silvio O. Conte, a U.S. congressman and advocate for mental health research, will study the onset of schizophrenia. Schizophrenia is a disease with cognitive dysfunction, affecting approximately one percent of the population worldwide.

The center, based on both NYU School of Medicine (a part of NYU Langone Medical Center) and the Nathan Kline Institute for Psychiatric Research, a New York State-funded affiliate located in Orangeburg, New York, will investigate the link between schizophrenia and dysfunctional brain N-methyl-D-aspartate receptors (NMDA). NMDA receptors are vital to learning, brain development, and the formation of short-term memories that the brain relies on to make sense of the surrounding environment. NMDA dysfunction is thought to play a key role in schizophrenia. The research conducted by the center will challenge the long-held belief that an excess of dopamine is the primary cause of schizophrenia, and will be led by Daniel C. Javitt, MD, PhD, professor of psychiatry and neuroscience at NYU Langone Medical Center and director of the Schizophrenia Research Center at the Nathan Kline Institute. The team also includes investigators from the University of California, San Diego; Zucker Hillside Hospital in Glen Oaks, New York; and Sheba Hospital in Tel Aviv, Israel.

"Through our collective findings, this new Conte Center will allow us to move forward with research aimed at uncovering further the beginnings of schizophrenia to help develop more effective treatments for this debilitating disease," said Vivian S. Lee, MD, PhD, MBA, senior vice president, vice dean for science and chief scientific officer. "This grant recognizes the extraordinary researchers at NYU School of Medicine and encourages the collaborative efforts of experts in this field across several institutions."

A key goal of the center is to begin identifying pre-symptomatic individuals in adolescence in order to intervene before the disease's permanent effects take hold. Researchers will use tools such as EEG readings and brain scans to study how new NMDA-receptor-enhancing therapies affect patients as well as the effects of NMDA-receptor-blocking drugs, such as ketamine, in animal models of schizophrenia.

In addition to core research funding, NIHMH awarded the center an additional $150,000 per year to support a summer undergraduate research program beginning next year.
-end-
Since 1988, NIMH has encouraged scientists to seek funding for projects in which a unifying, well-defined scientific question would be approached by many angles and at many levels through its Centers for Neuroscience of Mental Disorders and Centers for Neuroscience Research. Each of the funded centers must be capable of conducting cutting-edge research with an eye for translation of basic research findings to mental health.

About NYU Langone Medical Center

NYU Langone Medical Center is one of the nation's premier centers of excellence in healthcare, biomedical research, and medical education. For over 168 years, NYU physicians and researchers have made countless contributions to the practice and science of health care. Today the Medical Center consists of NYU School of Medicine, including the Smilow Research Center, the Skirball Institute of Biomolecular Medicine, and the Sackler Institute of Graduate Biomedical Sciences; the three hospitals of NYU Hospitals Center, Tisch Hospital, a 705-bed acute-care general hospital, Rusk Institute of Rehabilitation Medicine, the first and largest facility of its kind, and NYU Hospital for Joint Diseases, a leader in musculoskeletal care; and such major programs as the NYU Cancer Institute, the NYU Child Study Center, and the Hassenfeld Children's Center for Cancer and Blood Disorders.

About the Nathan Kline Institute for Psychiatric Research

The Nathan Kline Institute for Psychiatric Research is a facility of the New York State Office of Mental Health. Affiliated with New York University Langone Medical Center, NKI is known nationally and internationally for its pioneering contributions to psychiatric research. For additional information please visit http://www.rfmh.org/nki

NYU Langone Medical Center / New York University School of Medicine

Related Schizophrenia Articles from Brightsurf:

Schizophrenia: When the thalamus misleads the ear
Scientists at the University of Geneva (UNIGE) and the Synapsy National Centre of Competence in Research (NCCR) have succeeded in linking the onset of auditory hallucinations - one of the most common symptoms of schizophrenia - with the abnormal development of certain substructures of a region deep in the brain called the thalamus.

Unlocking schizophrenia
New research, led by Prof. LIU Bing and Prof. JIANG Tianzi from the Institute of Automation of the Chinese Academy of Sciences and their collaborators have recently developed a novel imaging marker that may help in the personalized medicine of psychiatric disorders.

Researchers discover second type of schizophrenia
In a study of more than 300 patients from three continents, over one third had brains that looked similar to healthy people.

New clues into the genetic origins of schizophrenia
The first genetic analysis of schizophrenia in an ancestral African population, the South African Xhosa, appears in the Jan.

Dietary supplement may help with schizophrenia
A dietary supplement, sarcosine, may help with schizophrenia as part of a holistic approach complementing antipsychotic medication, according to a UCL researcher.

Schizophrenia: Adolescence is the game-changer
Schizophrenia may be related to the deletion syndrome. However, not everyone who has the syndrome necessarily develops psychotic symptoms.

Study suggests overdiagnosis of schizophrenia
In a small study of patients referred to the Johns Hopkins Early Psychosis Intervention Clinic (EPIC), Johns Hopkins Medicine researchers report that about half the people referred to the clinic with a schizophrenia diagnosis didn't actually have schizophrenia.

The ways of wisdom in schizophrenia
Researchers at UC San Diego School of Medicine report that persons with schizophrenia scored lower on a wisdom assessment than non-psychiatric comparison participants, but that there was considerable variability in levels of wisdom, and those with higher scores displayed fewer psychotic symptoms.

Recognizing the uniqueness of different individuals with schizophrenia
Individuals diagnosed with schizophrenia differ greatly from one another. Researchers from Radboud university medical center, along with colleagues from England and Norway, have demonstrated that very few identical brain differences are shared amongst different patients.

Resynchronizing neurons to erase schizophrenia
Today, a decisive step in understanding schizophrenia has been taken.

Read More: Schizophrenia News and Schizophrenia Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.